Previous studies have showed that TGF beta1 mediated the inhibition of JAK2/STAT3 and PI3K/AKT signaling pathways via SH2B3, reducing lung cancer anoikis resistance and suppressing cancer cell proliferation, migration, and EMT51. Here, JAK2 is linked to lung cancer.